Global Genomics Combined Artificial Intelligence Market Research Report 2025

Publication ID:

PB503255435

Publication Date:

April 1, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

The global market for Genomics Combined Artificial Intelligence was valued at US$ 785 million in the year 2024 and is projected to reach a revised size of US$ 1500 million by 2031, growing at a CAGR of 10.7% during the forecast period.
The companies of Genomics Combined Artificial Intelligence use deep learning to mine vast amounts of genetic information for new clues about disease, diagnosis or treatment and combine the amazing potential in AI and genetics for opening new horizons in healthcare.
Market Overview:
The combination of AI and genomics has transformed the healthcare, pharmaceutical, and biotech sectors. Rapid advances in genome sequencing technologies, coupled with AI-driven data analytics, are revolutionizing drug discovery, disease diagnostics, and precision medicine.
Key Market Trends:
Adoption of machine learning (ML) and deep learning (DL) algorithms for genomic data interpretation. Expansion of direct-to-consumer (DTC) genomic testing combined with AI for ancestry and health risk assessment. Increasing collaborations between pharmaceutical giants and AI-driven biotech startups. AI-driven genome editing tools such as CRISPR optimization.
Market Regional Analysis:
The United States leads in research, investment, and AI-driven genomics startups. Strong regulatory frameworks and government initiatives such as NIH funding and AI-driven health policies have fueled growth. Europe is increasingly focusing on precision medicine and AI-based genomic research, supported by regulatory agencies such as the European Health Data Space (EHDS). Asia Pacific is the fastest-growing market, led by China, Japan, and India. China鈥檚 government-backed AI and genomics initiatives and significant private sector investment have fueled rapid expansion.
Market Development Opportunities and Risks:
AI-driven genomics enhances treatment plans for patients and improves clinical outcomes. AI-driven drug discovery reduces the time and cost required to develop new drugs. Advances in AI-driven genome editing improve the precision of CRISPR-based gene therapies. Integration with cloud computing facilitates large-scale genomic data analysis and AI model training. The growth of telemedicine and DTC genetic testing expands consumers' access to genomic insights. AI-driven genomic analysis requires large data sets, posing safety and ethical challenges. Global regulation of genetic data use and AI-driven diagnostics varies. High cost and complexity: Despite cost reductions, AI-driven genomic solutions remain expensive in some regions. AI models trained on biased data sets may produce inaccurate genomic interpretations.
This report aims to provide a comprehensive presentation of the global market for Genomics Combined Artificial Intelligence, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genomics Combined Artificial Intelligence.
The Genomics Combined Artificial Intelligence market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Genomics Combined Artificial Intelligence market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genomics Combined Artificial Intelligence companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Deep Genomics
Verge Genomics
Verily Life Sciences
DeCODE
GenBio AI
Insilico Medicine
Tempus
Insitro
Immunai
Segment by Type
Pharmaco Genomics
Personal Genomics
Segment by Application
Hereditary Disease Genetic Testing
Cancer Genetic Testing
Ancestry & Traits Genetic Testing
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genomics Combined Artificial Intelligence company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genomics Combined Artificial Intelligence Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Pharmaco Genomics
1.2.3 Personal Genomics
1.3 Market by Application
1.3.1 Global Genomics Combined Artificial Intelligence Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hereditary Disease Genetic Testing
1.3.3 Cancer Genetic Testing
1.3.4 Ancestry & Traits Genetic Testing
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genomics Combined Artificial Intelligence Market Perspective (2020-2031)
2.2 Global Genomics Combined Artificial Intelligence Growth Trends by Region
2.2.1 Global Genomics Combined Artificial Intelligence Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Genomics Combined Artificial Intelligence Historic Market Size by Region (2020-2025)
2.2.3 Genomics Combined Artificial Intelligence Forecasted Market Size by Region (2026-2031)
2.3 Genomics Combined Artificial Intelligence Market Dynamics
2.3.1 Genomics Combined Artificial Intelligence Industry Trends
2.3.2 Genomics Combined Artificial Intelligence Market Drivers
2.3.3 Genomics Combined Artificial Intelligence Market Challenges
2.3.4 Genomics Combined Artificial Intelligence Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genomics Combined Artificial Intelligence Players by Revenue
3.1.1 Global Top Genomics Combined Artificial Intelligence Players by Revenue (2020-2025)
3.1.2 Global Genomics Combined Artificial Intelligence Revenue Market Share by Players (2020-2025)
3.2 Global Top Genomics Combined Artificial Intelligence Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Genomics Combined Artificial Intelligence Revenue
3.4 Global Genomics Combined Artificial Intelligence Market Concentration Ratio
3.4.1 Global Genomics Combined Artificial Intelligence Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genomics Combined Artificial Intelligence Revenue in 2024
3.5 Global Key Players of Genomics Combined Artificial Intelligence Head office and Area Served
3.6 Global Key Players of Genomics Combined Artificial Intelligence, Product and Application
3.7 Global Key Players of Genomics Combined Artificial Intelligence, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Genomics Combined Artificial Intelligence Breakdown Data by Type
4.1 Global Genomics Combined Artificial Intelligence Historic Market Size by Type (2020-2025)
4.2 Global Genomics Combined Artificial Intelligence Forecasted Market Size by Type (2026-2031)
5 Genomics Combined Artificial Intelligence Breakdown Data by Application
5.1 Global Genomics Combined Artificial Intelligence Historic Market Size by Application (2020-2025)
5.2 Global Genomics Combined Artificial Intelligence Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Genomics Combined Artificial Intelligence Market Size (2020-2031)
6.2 North America Genomics Combined Artificial Intelligence Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Genomics Combined Artificial Intelligence Market Size by Country (2020-2025)
6.4 North America Genomics Combined Artificial Intelligence Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genomics Combined Artificial Intelligence Market Size (2020-2031)
7.2 Europe Genomics Combined Artificial Intelligence Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Genomics Combined Artificial Intelligence Market Size by Country (2020-2025)
7.4 Europe Genomics Combined Artificial Intelligence Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genomics Combined Artificial Intelligence Market Size (2020-2031)
8.2 Asia-Pacific Genomics Combined Artificial Intelligence Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Genomics Combined Artificial Intelligence Market Size by Region (2020-2025)
8.4 Asia-Pacific Genomics Combined Artificial Intelligence Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genomics Combined Artificial Intelligence Market Size (2020-2031)
9.2 Latin America Genomics Combined Artificial Intelligence Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Genomics Combined Artificial Intelligence Market Size by Country (2020-2025)
9.4 Latin America Genomics Combined Artificial Intelligence Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genomics Combined Artificial Intelligence Market Size (2020-2031)
10.2 Middle East & Africa Genomics Combined Artificial Intelligence Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Genomics Combined Artificial Intelligence Market Size by Country (2020-2025)
10.4 Middle East & Africa Genomics Combined Artificial Intelligence Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Deep Genomics
11.1.1 Deep Genomics Company Details
11.1.2 Deep Genomics Business Overview
11.1.3 Deep Genomics Genomics Combined Artificial Intelligence Introduction
11.1.4 Deep Genomics Revenue in Genomics Combined Artificial Intelligence Business (2020-2025)
11.1.5 Deep Genomics Recent Development
11.2 Verge Genomics
11.2.1 Verge Genomics Company Details
11.2.2 Verge Genomics Business Overview
11.2.3 Verge Genomics Genomics Combined Artificial Intelligence Introduction
11.2.4 Verge Genomics Revenue in Genomics Combined Artificial Intelligence Business (2020-2025)
11.2.5 Verge Genomics Recent Development
11.3 Verily Life Sciences
11.3.1 Verily Life Sciences Company Details
11.3.2 Verily Life Sciences Business Overview
11.3.3 Verily Life Sciences Genomics Combined Artificial Intelligence Introduction
11.3.4 Verily Life Sciences Revenue in Genomics Combined Artificial Intelligence Business (2020-2025)
11.3.5 Verily Life Sciences Recent Development
11.4 DeCODE
11.4.1 DeCODE Company Details
11.4.2 DeCODE Business Overview
11.4.3 DeCODE Genomics Combined Artificial Intelligence Introduction
11.4.4 DeCODE Revenue in Genomics Combined Artificial Intelligence Business (2020-2025)
11.4.5 DeCODE Recent Development
11.5 GenBio AI
11.5.1 GenBio AI Company Details
11.5.2 GenBio AI Business Overview
11.5.3 GenBio AI Genomics Combined Artificial Intelligence Introduction
11.5.4 GenBio AI Revenue in Genomics Combined Artificial Intelligence Business (2020-2025)
11.5.5 GenBio AI Recent Development
11.6 Insilico Medicine
11.6.1 Insilico Medicine Company Details
11.6.2 Insilico Medicine Business Overview
11.6.3 Insilico Medicine Genomics Combined Artificial Intelligence Introduction
11.6.4 Insilico Medicine Revenue in Genomics Combined Artificial Intelligence Business (2020-2025)
11.6.5 Insilico Medicine Recent Development
11.7 Tempus
11.7.1 Tempus Company Details
11.7.2 Tempus Business Overview
11.7.3 Tempus Genomics Combined Artificial Intelligence Introduction
11.7.4 Tempus Revenue in Genomics Combined Artificial Intelligence Business (2020-2025)
11.7.5 Tempus Recent Development
11.8 Insitro
11.8.1 Insitro Company Details
11.8.2 Insitro Business Overview
11.8.3 Insitro Genomics Combined Artificial Intelligence Introduction
11.8.4 Insitro Revenue in Genomics Combined Artificial Intelligence Business (2020-2025)
11.8.5 Insitro Recent Development
11.9 Immunai
11.9.1 Immunai Company Details
11.9.2 Immunai Business Overview
11.9.3 Immunai Genomics Combined Artificial Intelligence Introduction
11.9.4 Immunai Revenue in Genomics Combined Artificial Intelligence Business (2020-2025)
11.9.5 Immunai Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Deep Genomics
Verge Genomics
Verily Life Sciences
DeCODE
GenBio AI
Insilico Medicine
Tempus
Insitro
Immunai

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂